127 related articles for article (PubMed ID: 81476)
41. Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanoma.
Isbister WH; Noonan FP; Halliday WJ; Clunie GJ
Cancer; 1975 May; 35(5):1465-71. PubMed ID: 1122496
[TBL] [Abstract][Full Text] [Related]
42. [Immunological aspects in malignant melanoma].
Macher E
Arch Dermatol Forsch; 1972; 244():234-9. PubMed ID: 4675197
[No Abstract] [Full Text] [Related]
43. [Aspects of immunologic diagnosis of brain tumors. Results with tumor-associated membrane antigens and the electrophoretic mobility test (author's transl)].
Meyer-Rienecker H; Jenssen HL; Werner H
Arch Psychiatr Nervenkr (1970); 1979; 227(2):121-33. PubMed ID: 543792
[TBL] [Abstract][Full Text] [Related]
44. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
45. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
Roth JA; Grimm EA; Morton DL
Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
[TBL] [Abstract][Full Text] [Related]
46. [Diagnosis of malignant melanomas. 2. Immunodiagnosis in malignant melanoma].
Sochor H; Redmann K; Kühne KH
Dermatol Monatsschr; 1978 Feb; 164(2):114-9. PubMed ID: 648688
[No Abstract] [Full Text] [Related]
47. Characterisation of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes.
Lui VK; Dent PB; Liao SK
Oncology; 1977; 34(6):251-4. PubMed ID: 593653
[TBL] [Abstract][Full Text] [Related]
48. Immunologic mechanisms in malignant melanoma of the skin.
Cochran AJ
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
[No Abstract] [Full Text] [Related]
49. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
Nitzschke U; Zwergel T; Lampert F
Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
[TBL] [Abstract][Full Text] [Related]
50. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
51. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
Saal JG; Rieber EP; Riethmüller G
Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
[TBL] [Abstract][Full Text] [Related]
52. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
53. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
Marti JH; Thomson DM
Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
[TBL] [Abstract][Full Text] [Related]
54. [Immunological analysis of melanoma specific antigen. (I). In-vitro induction of melanoma-antigen specific killer T lymphocytes in primary immune response].
Wakabayashi S; Taniguchi M; Tomioka H; Okamoto S
Nihon Hifuka Gakkai Zasshi; 1983 Dec; 93(14):1469-76. PubMed ID: 6676498
[No Abstract] [Full Text] [Related]
55. [Value of serologic tumor tests in malignant melanoma of the choroid].
Dieckhues B
Klin Monbl Augenheilkd; 1986 Feb; 188(2):114-7. PubMed ID: 3713079
[TBL] [Abstract][Full Text] [Related]
56. Vaccination for malignant melanoma: recent developments.
Jäger D; Jäger E; Knuth A
Oncology; 2001; 60(1):1-7. PubMed ID: 11150901
[TBL] [Abstract][Full Text] [Related]
57. The significance of urinary melanoma antigen excretion and the ability of thymosin to raise the level of depleted lymphocytes in vitro in malignant melanoma.
Volkers C; Cooke B; Bennett C; Byrom N; Campbell M; Elliot P; Whitfield P
Aust N Z J Surg; 1978 Feb; 48(1):32-6. PubMed ID: 307381
[TBL] [Abstract][Full Text] [Related]
58. Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
Minderhoud JM; Smith JK
Clin Exp Immunol; 1972 Apr; 10(4):571-9. PubMed ID: 5034245
[TBL] [Abstract][Full Text] [Related]
59. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
60. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
Char DH
Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
